BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17257495)

  • 1. Relationship between cytokines and leukocytosis in patients with APL induced by all-trans retinoic acid or arsenic trioxide.
    Bi KH; Jiang GS
    Cell Mol Immunol; 2006 Dec; 3(6):421-7. PubMed ID: 17257495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of cytokines on hyperleukocytosis associated with acute promyelocytic leukemia induced by all-trans retinoic acid therapy].
    Hino K; Nakamaki T
    Rinsho Ketsueki; 1996 Sep; 37(9):770-6. PubMed ID: 8914460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis induction by (+)alpha-tocopheryl succinate in the absence or presence of all-trans retinoic acid and arsenic trioxide in NB4, NB4-R2 and primary APL cells.
    Freitas RA; Silva dos Santos GA; Gimenes Teixeira HL; Scheucher PS; Lucena-Araujo AR; Lima AS; Abreu e Lima RS; Garcia AB; Jordão AA; Falcão RP; Vannucchi H; Rego EM
    Leuk Res; 2009 Jul; 33(7):958-63. PubMed ID: 19013639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperleukocytosis from arsenic trioxide.
    Levy M; Wofford MM; Powell BL; McLean TW
    Pediatr Blood Cancer; 2008 Jun; 50(6):1265-7. PubMed ID: 18300308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukocytosis and the retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxide.
    Camacho LH; Soignet SL; Chanel S; Ho R; Heller G; Scheinberg DA; Ellison R; Warrell RP
    J Clin Oncol; 2000 Jul; 18(13):2620-5. PubMed ID: 10893295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adhesion molecules and Differentiation Syndrome: phenotypic and functional analysis of the effect of ATRA, As2O3, phenylbutyrate, and G-CSF in acute promyelocytic leukemia.
    Cunha De Santis G; Tamarozzi MB; Sousa RB; Moreno SE; Secco D; Garcia AB; Lima AS; Faccioli LH; Falcão RP; Cunha FQ; Rego EM
    Haematologica; 2007 Dec; 92(12):1615-22. PubMed ID: 18055984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. All-trans-retinoic acid and arsenic trioxide as initial therapy for acute promyelocytic leukemia.
    Quezada G; Kopp L; Estey E; Wells RJ
    Pediatr Blood Cancer; 2008 Jul; 51(1):133-5. PubMed ID: 18293388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia.
    Zheng PZ; Wang KK; Zhang QY; Huang QH; Du YZ; Zhang QH; Xiao DK; Shen SH; Imbeaud S; Eveno E; Zhao CJ; Chen YL; Fan HY; Waxman S; Auffray C; Jin G; Chen SJ; Chen Z; Zhang J
    Proc Natl Acad Sci U S A; 2005 May; 102(21):7653-8. PubMed ID: 15894607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic trioxide: new clinical experience with an old medication in hematologic malignancies.
    Douer D; Tallman MS
    J Clin Oncol; 2005 Apr; 23(10):2396-410. PubMed ID: 15800332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of arsenic trioxide on cytokine expression by acute promyelocytic leukemia cells.
    Jiang G; Bi K; Tang T; Zhang Y; Ren H; Jiang F; Ren Q; Zhen G; Liu C; Peng J; Guo G; Liu X; Tian Z
    Chin Med J (Engl); 2003 Nov; 116(11):1639-43. PubMed ID: 14642127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiating agents in pediatric malignancies: all-trans-retinoic acid and arsenic in acute promyelocytic leukemia.
    Calleja EM; Warrell RP
    Curr Oncol Rep; 2000 Nov; 2(6):519-23. PubMed ID: 11122887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic trioxide represses NF-kappaB activation and increases apoptosis in ATRA-treated APL cells.
    Mathieu J; Besançon F
    Ann N Y Acad Sci; 2006 Dec; 1090():203-8. PubMed ID: 17384263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycolytic metabolism confers resistance to combined all-trans retinoic acid and arsenic trioxide-induced apoptosis in HL60rho0 cells.
    Herst PM; Hesketh EL; Ritchie DS; Berridge MV
    Leuk Res; 2008 Feb; 32(2):327-33. PubMed ID: 17580091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The kinetics of white blood cell and the predictive factors of leukocytosis under oral or intravenous arsenic as the first-line treatment for acute promyelocytic leukemia.
    Wang F; Jia JS; Wang J; Zhao T; Jiang Q; Jiang H; Zhu HH
    Leuk Res; 2017 Oct; 61():84-88. PubMed ID: 28934679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [G-CSF and all-trans retinoic acid-induced leukocytosis].
    Wu W; Sun G; Wu W
    Zhonghua Zhong Liu Za Zhi; 1996 Jul; 18(4):273-5. PubMed ID: 9387319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Myc in differentiation and apoptosis in HL60 cells after exposure to arsenic trioxide or all-trans retinoic acid.
    Jiang G; Albihn A; Tang T; Tian Z; Henriksson M
    Leuk Res; 2008 Feb; 32(2):297-307. PubMed ID: 17706770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic trioxide: new preparation. Acute promyelocytic leukaemia: encouraging results but persistent doubts.
    Prescrire Int; 2004 Aug; 13(72):135-7. PubMed ID: 15532137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the role of arsenic in newly diagnosed APL?
    Tallman MS
    Best Pract Res Clin Haematol; 2008 Dec; 21(4):659-66. PubMed ID: 19041605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PLC-beta2 monitors the drug-induced release of differentiation blockade in tumoral myeloid precursors.
    Brugnoli F; Bovolenta M; Benedusi M; Miscia S; Capitani S; Bertagnolo V
    J Cell Biochem; 2006 May; 98(1):160-73. PubMed ID: 16408290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arsenic trioxide in the management of acute promyelocytic leukaemia.
    Mathews V; Chandy M; Srivastava A
    Natl Med J India; 2001; 14(4):215-22. PubMed ID: 11547528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.